Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Eric G. Sahloff"'
Autor:
Marisa Brizzi, Elizabeth M. Sherman, Sarah B. Green, Diana N. Nowicki, Emily N. Drwiega, Melanie R. Nicol, Daniel B. Chastain, Eric G. Sahloff, William R. Truong, David Cluck, Melissa E. Badowski, Sarah M. Michienzi, Spencer H. Durham
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43:305-320
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df773238123581c8431120a97da08afc
https://doi.org/10.1002/phar.2796
https://doi.org/10.1002/phar.2796
Publikováno v:
Open forum infectious diseases. 9(7)
Long-acting cabotegravir (CAB-LA) provides an exciting new option for pre-exposure prophylaxis (PrEP) in multiple populations. In this Perspective, we consider the unique pharmacokinetics of CAB-LA and the potential impact on the prescribing of CAB-L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b6788c82a183be7a75c04355071141
https://pubmed.ncbi.nlm.nih.gov/35836749
https://pubmed.ncbi.nlm.nih.gov/35836749
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
Purpose Data support the individual and public health advantages of shortened time intervals between HIV diagnosis, initiation of antiretroviral therapy (ART), and virologic suppression. The time from HIV diagnosis to linkage to care, initiation of A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13d813cd2c5c0aaae599f9f37ec5733
https://pubmed.ncbi.nlm.nih.gov/34185842
https://pubmed.ncbi.nlm.nih.gov/34185842
Publikováno v:
Journal of Pharmacy Practice. 34:224-229
Background: Few published studies have examined the relationship between pharmacy location and retention in care or clinical outcome in people living with HIV (PLWH). Objective: The study purpose was to determine whether using an on-site/in-clinic ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad4a20dab2f8ebe74a9fbfccae5c8da
https://doi.org/10.1177/0897190019866324
https://doi.org/10.1177/0897190019866324
Autor:
Eric G. Sahloff, Joan Duggan
Publikováno v:
Annals of Pharmacotherapy. 53:50-55
Background: Limited data exist on the use of a boosted protease inhibitor plus 24 weeks. Methods: This was a single-center chart review of HIV-infected patients receiving daily TDF/FTC plus DRV/r and identified with resistant virus (including, but no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db360eedcbced354ff67f6582dc1c6b1
https://doi.org/10.1177/1060028018790574
https://doi.org/10.1177/1060028018790574
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0d07febe47417c693181fb19c3e8cca
https://doi.org/10.1093/ofid/ofw172.353
https://doi.org/10.1093/ofid/ofw172.353
Publikováno v:
Open Forum Infectious Diseases
This retrospective chart review evaluated changes in serum creatinine and creatinine clearance (CrCl) after initiation of an integrase inhibitor (INSTI)-based regimen as initial treatment in human immunodeficiency virus-infected adults. Serum creatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a88f9f41d1fe8e4c750cf2ac21bc238c
https://doi.org/10.1093/ofid/ofw053
https://doi.org/10.1093/ofid/ofw053
Autor:
Joan Duggan, Eric G. Sahloff
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9d61d9418b6813911ce90075c6714f5
https://doi.org/10.1093/ofid/ofw172.1698
https://doi.org/10.1093/ofid/ofw172.1698
Publikováno v:
American Journal of Health-System Pharmacy. 66:715-726
Purpose. The mechanism of action, pharmacology, pharmacokinetics, clinical efficacy, drug interactions, adverse effects, dosage and administration, cost, and role in therapy of maraviroc are reviewed. Summary. Maraviroc is the first CCR5 coreceptor a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36666c9258bc11fad533b499a3328c50
https://doi.org/10.2146/ajhp080206
https://doi.org/10.2146/ajhp080206
Publikováno v:
Journal of Pharmacy Practice. 23:128-134
The level of patient-pharmacist interactions and services provided varies across different distribution methods and could affect patient satisfaction with services. Determining patient satisfaction with these medication distribution methods is import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31045595c94dd9dec073356cd526885e
https://doi.org/10.1177/0897190009334329
https://doi.org/10.1177/0897190009334329